Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases
Hong-Yi Zhang1, Ya-Lin Kong, Hong-Yi Zhang
1Department of Hepatobiliary Surgery, General Hospital of Air Force PLA, Beijing 100036, China. zhhyiyi1487@163.com
Background:
The incidence of hepatic portal cholangiocarcinoma is increasing and it is always associated with poor survival. This study analyzed an effective therapeutic method.
Methods:
A retrospective analysis was made on 70 patients with hepatic portal cholangiocarcinoma admitted between January 2004 and February 2007 to the General Hospital of Air Force PLA.
Results:
Forty-seven patients had hepatic duct-jejunum anastomosis after resection of hepatic portal cholangiocarcinoma. Internal or external biliary drainage and canals for internal radiation were performed in those patients unfit for operation. Among the 70 patients, 5 died within 15 months, 27 survived more than 24 months, and the others survived 4-18 months.
Conclusion:
Surgery is the primary therapeutic method for hepatic portal cholangiocarcinoma. Internal or external biliary drainage can prolong the life-span.
Related Concept Videos
01:22Portal Hypertension
01:21Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...